Clinical trial
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage…
NCT00002864 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00002864 |
|---|---|
| Title | Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer |
| Official title | A Randomized Trial of Antiestrogen Therapy Versus Combined Antiestrogen and Octreotide Therapy in the Adjuvant Treatment of Breast Cancer in Post-Menopausal Women |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | octreotide acetate, tamoxifen citrate |
| Enrollment | 667 |
| Start date | Sep 24, 1996 |
| Primary completion | Dec 7, 2007 |
| Completion | Apr 23, 2010 |
| First posted | Jun 16, 2004 |
| Last update posted | Apr 1, 2020 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: